146 related articles for article (PubMed ID: 12759526)
1. A Systemic Hyperthermia Oncologic Working Group trial. Ifosfamide, carboplatin, and etoposide combined with 41.8 degrees C whole-body hyperthermia for metastatic soft tissue sarcoma.
Westermann AM; Wiedemann GJ; Jager E; Jager D; Katschinski DM; Knuth A; Vörde Sive Vörding PZ; Van Dijk JD; Finet J; Neumann A; Longo W; Bakhshandeh A; Tiggelaar CL; Gillis W; Bailey H; Peters SO; Robins HI;
Oncology; 2003; 64(4):312-21. PubMed ID: 12759526
[TBL] [Abstract][Full Text] [Related]
2. Ifosfamide, carboplatin and etoposide (ICE) combined with 41.8 degrees C whole body hyperthermia in patients with refractory sarcoma.
Wiedemann GJ; Robins HI; Gutsche S; Mentzel M; Deeken M; Katschinski DM; Eleftheriadis S; Crahé R; Weiss C; Storer B; Wagner T
Eur J Cancer; 1996 May; 32A(5):888-92. PubMed ID: 9081372
[TBL] [Abstract][Full Text] [Related]
3. Ifosfamide, carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pre-treated advanced soft tissue sarcoma of adults.
Fiegl M; Schlemmer M; Wendtner CM; Abdel-Rahman S; Fahn W; Issels RD
Int J Hyperthermia; 2004 Sep; 20(6):661-70. PubMed ID: 15370821
[TBL] [Abstract][Full Text] [Related]
4. Systemic hyperthermia and ICE chemotherapy for sarcoma patients: rationale and clinical status.
Wiedemann GJ; Robins HI; Katschinski DM; Mentzel M; D'Oleire F; Kutz M; Wagner T
Anticancer Res; 1997; 17(4B):2899-902. PubMed ID: 9329558
[TBL] [Abstract][Full Text] [Related]
5. Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
Chang AY; Boros L; Garrow GC; Asbury RF; Hui L
Semin Oncol; 1996 Jun; 23(3 Suppl 6):74-7. PubMed ID: 8677454
[TBL] [Abstract][Full Text] [Related]
6. Ifosfamide and carboplatin combined with 41.8 degrees C whole-body hyperthermia in patients with refractory sarcoma and malignant teratoma.
Wiedemann GJ; d'Oleire F; Knop E; Eleftheriadis S; Bucsky P; Feddersen S; Klouche M; Geisler J; Mentzel M; Schmucker P
Cancer Res; 1994 Oct; 54(20):5346-50. PubMed ID: 7923163
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of consolidation high-dose chemotherapy with ifosfamide, carboplatin and etoposide (HD-ICE) followed by autologous peripheral blood stem cell rescue in chemosensitive patients with metastatic soft tissue sarcomas.
Schlemmer M; Wendtner CM; Falk M; Abdel-Rahman S; Licht T; Baumert J; Straka C; Hentrich M; Salat C; Hiddemann W; Issels RD
Oncology; 2006; 71(1-2):32-9. PubMed ID: 17344669
[TBL] [Abstract][Full Text] [Related]
8. Nephrotoxicity of ifosfamide, carboplatin and etoposide (ICE) alone or combined with extracorporeal or radiant-heat-induced whole-body hyperthermia.
Gerke P; Filejski W; Robins HI; Wiedemann GJ; Steinhoff J
J Cancer Res Clin Oncol; 2000 Mar; 126(3):173-7. PubMed ID: 10741912
[TBL] [Abstract][Full Text] [Related]
9. Preoperative systemic etoposide/ifosfamide/doxorubicin chemotherapy combined with regional hyperthermia in high-risk sarcoma: a pilot study.
Issels RD; Bosse D; Abdel-Rahman S; Starck M; Panzer M; Jauch KW; Stiegler H; Berger H; Sauer H; Peter K
Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S233-7. PubMed ID: 8453705
[TBL] [Abstract][Full Text] [Related]
10. Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: a phase II study.
Issels RD; Prenninger SW; Nagele A; Boehm E; Sauer H; Jauch KW; Denecke H; Berger H; Peter K; Wilmanns W
J Clin Oncol; 1990 Nov; 8(11):1818-29. PubMed ID: 2121910
[TBL] [Abstract][Full Text] [Related]
11. Optimization of chemotherapy administration for clinical 41.8 degrees C whole body hyperthermia.
Katschinski DM; Wiedemann GJ; Mentzel M; Mulkerin DL; Touhidi R; Robins HI
Cancer Lett; 1997 May; 115(2):195-9. PubMed ID: 9149124
[TBL] [Abstract][Full Text] [Related]
12. Ifosfamide, carboplatin and etoposide combined with 41.8 degrees C whole body hyperthermia for malignant pleural mesothelioma.
Bakhshandeh A; Bruns I; Traynor A; Robins HI; Eberhardt K; Demedts A; Kaukel E; Koschel G; Gatzemeier U; Kohlmann T; Dalhoff K; Ehlers EM; Gruber Y; Zumschlinge R; Hegewisch-Becker S; Peters SO; Wiedemann GJ
Lung Cancer; 2003 Mar; 39(3):339-45. PubMed ID: 12609573
[TBL] [Abstract][Full Text] [Related]
13. Ifosfamide and continuous infusion etoposide in advanced adult soft tissue sarcoma. A Scandinavian Sarcoma Group Phase II Study.
Saeter G; Alvegård TA; Monge OR; Strander H; Turesson I; Klepp R; Söderberg M; Wist E; Raabe N; Erlanson M; Solheim OP; Hannisdal E
Eur J Cancer; 1997 Sep; 33(10):1551-8. PubMed ID: 9389914
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the therapeutic benefit of 41.8 degrees C whole body hyperthermia plus ifosfamide, carboplatin and etoposide (ICE) for patients with malignant pleural mesothelioma using the Modified Brunner-Score (MBS)].
Bruns I; Kohlmann T; Wiedemann GJ; Bakhshandeh A
Pneumologie; 2004 Apr; 58(4):210-6. PubMed ID: 15098157
[TBL] [Abstract][Full Text] [Related]
15. Treatment of advanced, high-grade soft-tissue sarcoma with ifosfamide and continuous-infusion etoposide.
Saeter G; Talle K; Solheim OP
Cancer Chemother Pharmacol; 1995; 36(2):172-5. PubMed ID: 7539339
[TBL] [Abstract][Full Text] [Related]
16. High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study.
Kleiner S; Kirsch A; Schwaner I; Kingreen D; Schwella N; Huhn D; Siegert W
Bone Marrow Transplant; 1997 Dec; 20(11):953-9. PubMed ID: 9422474
[TBL] [Abstract][Full Text] [Related]
17. Improvement of local control by regional hyperthermia combined with systemic chemotherapy (ifosfamide plus etoposide) in advanced sarcomas: updated report on 65 patients.
Issels RD; Mittermüller J; Gerl A; Simon W; Ortmaier A; Denzlinger C; Sauer H; Wilmanns W
J Cancer Res Clin Oncol; 1991; 117 Suppl 4():S141-7. PubMed ID: 1795003
[TBL] [Abstract][Full Text] [Related]
18. The role of hematopoietic growth factors in support of ifosfamide/carboplatin/etoposide chemotherapy.
Crawford J; George M
Semin Oncol; 1995 Jun; 22(3 Suppl 7):18-22. PubMed ID: 7541916
[TBL] [Abstract][Full Text] [Related]
19. A phase I clinical, pharmacologic, and biologic study of thrombopoietin and granulocyte colony-stimulating factor in children receiving ifosfamide, carboplatin, and etoposide chemotherapy for recurrent or refractory solid tumors: a Children's Oncology Group experience.
Angiolillo AL; Davenport V; Bonilla MA; van de Ven C; Ayello J; Militano O; Miller LL; Krailo M; Reaman G; Cairo MS;
Clin Cancer Res; 2005 Apr; 11(7):2644-50. PubMed ID: 15814645
[TBL] [Abstract][Full Text] [Related]
20. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
Brugger W; Frommhold H; Pressler K; Mertelsmann R; Kanz L
Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
